Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PD”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01975831
What this trial is testing

Evaluate MEDI4736 in Combination With Tremelimumab

Who this might be right for
Breast CancerOvarian CancerColorectal Cancer+2 more
Ludwig Institute for Cancer Research 104
Not applicableNot Yet RecruitingNCT06284629
What this trial is testing

Enhancing Referral Decision-making for Advanced Treatment in Parkinson's Disease Through Objective Measurements and Patient Reported Outcomes.

Who this might be right for
Parkinson Disease
Rigshospitalet, Denmark 90
Not applicableStudy completedNCT01602614
What this trial is testing

Evaluation of the Pharmacokinetics (PK) and Pharmacodymamics (PD) of Ganciclovir (GCV) in Premature Infants Receiving Treatment for Cytomegalorivus (CMV) Infection

Who this might be right for
Cytomegalovirus Infections
University of Alabama at Birmingham 18
Large-scale testing (Phase 3)Study completedNCT04102098
What this trial is testing

Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation

Who this might be right for
Carcinoma, Hepatocellular
Hoffmann-La Roche 668
Early research (Phase 1)Study completedNCT02418793
What this trial is testing

A Long-Acting r-Factor 7a (Factor VIIa) in Adult Men With Hemophilia A or B

Who this might be right for
Hemophilia AHemophilia B
OPKO Health, Inc. 27
Testing effectiveness (Phase 2)Looking for participantsNCT07322887
What this trial is testing

Assess the Effects of SUL-238 on High Energy Phosphates With ³¹P-MRS in Patients With Early, Untreated Parkinson's Disease

Who this might be right for
Parkinson's Disease (PD)
GEN İlaç ve Sağlık Ürünleri A.Ş. 45
Testing effectiveness (Phase 2)Ended earlyNCT03386721
What this trial is testing

Basket Study to Evaluate the Therapeutic Activity of Simlukafusp Alfa as a Combination Therapy in Participants With Advanced and/or Metastatic Solid Tumors

Who this might be right for
Advanced/Metastatic Head and Neck, Oesophageal and Cervical Cancers
Hoffmann-La Roche 256
Post-approval studies (Phase 4)UnknownNCT00492414
What this trial is testing

Costs of Lost Productive Time Among Korean Workers With Panic Disorder and Effect of Treatment With Paroxetine Controlled Release

Who this might be right for
Panic Disorder
Inje University
Early research (Phase 1)Study completedNCT04945421
What this trial is testing

IBI310 in Combination With Siltilimab in Subjects With Anti-PD-1/PD-L1 Resistance R/M NPC

Who this might be right for
NPC
Innovent Biologics (Suzhou) Co. Ltd. 30
Testing effectiveness (Phase 2)Looking for participantsNCT06579196
What this trial is testing

Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed Advanced NSCLC and Positive PD-L1

Who this might be right for
Non-small Cell Lung Cancer
University of Nebraska 45
Post-approval studies (Phase 4)Study completedNCT02365272
What this trial is testing

Pharmacokinetic/Pharmacodynamic Evaluation Amikacin in Critically Ill Patients Admitted at the Emergency Department

Who this might be right for
Sepsis
Universitaire Ziekenhuizen KU Leuven 100
Not applicableUnknownNCT05803746
What this trial is testing

PD-L2 Targeting Nanobody Radiotracer for PET Imaging of Solid Tumor

Who this might be right for
Lung CancerColorectal Cancer
Peking University Cancer Hospital & Institute 20
Testing effectiveness (Phase 2)Ended earlyNCT05159388
What this trial is testing

PRS-344/S095012 (PD-L1x4-1BB Bispecific Antibody) in Patients With Solid Tumors

Who this might be right for
Solid Tumor
Servier Bio-Innovation LLC 46
Not applicableStudy completedNCT01922388
What this trial is testing

Early Versus Late Application of STN DBS to PD Patients With Motor Complications

Who this might be right for
Parkinson Disease
Chen Ling 200
Testing effectiveness (Phase 2)Study completedNCT03220854
What this trial is testing

SBRT + PD-1/PDL-1 Inhibiting Therapy for Advanced Solid Tumors After Dz Control on PD-1/PDL-1 Tx

Who this might be right for
Solid Tumor
Virginia Commonwealth University 5
Testing effectiveness (Phase 2)Study completedNCT02860546
What this trial is testing

A Study Evaluating TAS-102 Plus Nivolumab in Patients With MSS CRC

Who this might be right for
Refractory Metastatic Colorectal Cancer
Taiho Oncology, Inc. 18
Not applicableLooking for participantsNCT05713994
What this trial is testing

Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Ze-yang Ding, MD 300
Very early researchStudy completedNCT01722669
What this trial is testing

Quercetin PK/PD Study in Healthy Adults and Patients With Hypercoagulable States

Who this might be right for
Healthy
Beth Israel Deaconess Medical Center 38
Early research (Phase 1)Study completedNCT01981694
What this trial is testing

A Phase I Trial to Investigate the Safety and Tolerability of PF-06649751

Who this might be right for
Healthy
Pfizer 18
Not applicableStudy completedNCT07659405
What this trial is testing

Trial of Four Spinal Cord Stimulation Paradigms for Gait Impairment in Parkinson's Disease

Who this might be right for
Parkinson's Disease (PD)Spinal Cord Stimulation (SCS)
University of Aarhus 11
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation